Association of LPIN1 gene variations with markers of metabolic syndrome in population from Bosnia and Herzegovina
- Tamer Bego (Faculty of Pharmacy, University of Sarajevo, Sarajevo, Department of Biochemistry and Clinical Analysis, Bosnia and Herzegovina)
- Tanja Dujić (Faculty of Pharmacy, University of Sarajevo, Sarajevo, Department of Biochemistry and Clinical Analysis, Bosnia and Herzegovina)
- Barbara Mlinar (Faculty of Pharmacy, University of Ljubljana, Ljubljana, Department of Clinical Biochemistry, Slovenia)
- Sabina Semiz (Faculty of Pharmacy, University of Sarajevo, Sarajevo, Department of Biochemistry and Clinical Analysis, Bosnia and Herzegovina)
- Maja Malenica (Faculty of Pharmacy, University of Sarajevo, Sarajevo, Department of Biochemistry and Clinical Analysis, Bosnia and Herzegovina)
- Besim Prnjavorac (General Hospital of Tešanj, Tešanj, Bosnia and Herzegovina)
- Barbara Ostanek (Faculty of Pharmacy, University of Ljubljana, Ljubljana, Department of Clinical Biochemistry, Slovenia)
- Janja Marc (Faculty of Pharmacy, University of Ljubljana, Ljubljana, Department of Clinical Biochemistry, Slovenia)
- Anida Čaušević-Ramoševac (Bosnalijek, Pharmaceutical and Chemical Industry, Joint Stock Company, Sarajevo, Bosnia and Herzegovina)
- Adlija Čaušević (Faculty of Pharmacy, University of Sarajevo, Sarajevo, Department of Biochemistry and Clinical Analysis, Bosnia and Herzegovina)
Abstract
Aim: To investigate association of two LPIN1 gene variations with main traits of metabolic syndrome (MS) (waist circumference, body mass index, blood pressure, triglycerides, HDL-cholesterol and fasting glucose levels) in population from Bosnia and Herzegovina.
Methods: This study included 43 patients with metabolic syndrome and 43 healthy controls from General Hospital in Tešanj, Bosnia and Herzegovina. Subjects were genotyped for two LPIN1 gene variations (rs11693809: C>T and rs2716610: C>T) by real time PCR method.
Results: In control subjects LPIN1 polymorphism, rs2716610: C>T, was significantly associated with a lower body mass index (BMI) (p=0.008) and waist circumference (p=0.008). The second analyzed rs11693809: C>T polymorphism was associated with lower blood HbA1c levels (p=0.048) in a group of MS patients.
Conclusion:
Results: of our study suggest that rs2716610: C>T polymorphism of LPIN1 gene could have a protective effect against development of metabolic syndrome, while rs11693809: C>T might affect a glucose control in patients with MS.
Keywords: metabolic syndrome, LPIN1 gene, markers, gene variations.
How to Cite:
Bego, T., Dujić, T., Mlinar, B., Semiz, S., Malenica, M., Prnjavorac, B., Ostanek, B., Marc, J., Čaušević-Ramoševac, A. & Čaušević, A., (2015) “Association of LPIN1 gene variations with markers of metabolic syndrome in population from Bosnia and Herzegovina”, Medicinski glasnik 13(2). doi: https://doi.org/10.17392/797-15
Downloads:
Download PDF
View PDF
0 Views
0 Downloads